LTFS
WX

Ladenburg Thalmann Financial Services’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,665
Closed -$72K – 4947
2015
Q3 		$72K Sell
1,665
-23
-1% -$971 ﹤0.01% 2225
2015
Q2 		$71K Sell
1,688
-195
-10% -$8.22K ﹤0.01% 2345
2015
Q1 		$73K Buy
1,883
+114
+6% +$4.39K ﹤0.01% 2295
2014
Q4 		$60K Sell
1,769
-77
-4% -$2.72K ﹤0.01% 2255
2014
Q3 		$65K Buy
1,846
+282
+18% +$9.67K ﹤0.01% 1873
2014
Q2 		$51K Buy
1,564
+216
+16% +$7.39K ﹤0.01% 2038
2014
Q1 		$50K Buy
1,348
+638
+90% +$23.4K ﹤0.01% 1980
2013
Q4 		$27K Buy
+710
New +$22.4K ﹤0.01% 2354

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Ladenburg Thalmann Financial Services's WX Position: Q4 2015 in Review

Ladenburg Thalmann Financial Services sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 1,665 shares — an estimated $72K sold.

Ladenburg Thalmann Financial Services first reported a position in WX in Q4 2013 and held it in 8 quarters. The position peaked at $73K in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Ladenburg Thalmann Financial Services reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 1,665 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $72K.
  • Ladenburg Thalmann Financial Services first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 8 quarters.
  • Ladenburg Thalmann Financial Services's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $73K in Q1 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2015, filed 16 Feb 2016.